Tag: Prescription Drugs
Prednisone Use Linked to Increased Risk of Mortality in RA
Risk attenuated when patients are treated with combination of prednisone and methotrexate
PPI Use Ups NSAID-Induced Small Bowel Injury
Increased risk of small bowel injury for healthy participants treated with celecoxib + PPI
Intermittent Steroids Reduce Some Asthma Exacerbations
Findings for preschool children with intermittent asthma or viral-triggered wheezing
New Findings Offer Hope for Those With Severe Hemophilia
One study pinpoints when standard therapy works best; another uncovers the promise of a new drug
Metformin Combats Adipose Tissue Expansion Via AMPK
AMPK activation is linked to inhibition of interstitial fibrosis, suppression of TGF-β1
Lip Cancer Risk Up for Some Solid Organ Transplant Recipients
Cancer risk up with high mean daily dose of azathioprine, longer duration of immunosupression
Two New Drugs Added to Heart Failure Clinical Practice Guideline
Heart groups issue updated guideline for the treatment of heart failure
Opioid Prescriptions Drop for First Time in Two Decades
Several health data companies report a 12 to 18 percent drop in prescriptions since 2012
![Treatment with sulfonylureas (ATP-sensitive potassium [KATP] channel blockers) may inhibit the neuroprotective effects of KATP channel activation and increase the risk of stroke](https://www.ehealth-news.com/wp-content/uploads/2016/05/18120-1.jpeg "Sulfonylureas May Inhibit KATP Channel Neuroprotection")
Sulfonylureas May Inhibit KATP Channel Neuroprotection
Treatment with sulfonylureas may increase the risk of stroke mortality in patients with type 2 diabetes
Danazol Treatment Linked to Telomere Elongation
Reduction in rate of telomere attrition at 24 months; gain in telomere length seen from six months
